Biomarkers, Diagnostics, and More

Diagnostics, Life Science, and Biotechnology Consulting for Investors, CEOs, and Functional | Department Heads

Category: Health Economics

Barriers to Personalized Medicine and Companion Diagnostics

October 11, 2016 Winton Gibbons

Posts navigation

Older posts

Blog Stats

20,277 hits

Contact Form

Please provide contact information (optional)

Name

What is your interest?

Do you have an immediate request?

(check if yes)

Company

Position

Follow me on Twitter

My Tweets

Winton quoted by

Biocentury, Bloomberg and Bloomberg TV, Boston Herald, CBS Market Watch, Chicago Tribune, CNBC TV, Dow Jones, Forbes, In Vivo, Investor’s Business Daily, MSNBC TV, Nature, New York Times, PBS, Reuters, San Francisco Chronicle, SmartMoney.com, TheStreet.com, USA Today, Wall Street Journal, Washington Post.

Search for:

Search archives by month

Search by category

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address:

RSS - Posts

Winton Gibbons

Diagnostics, Life Science, and Biotechnology Consulting for Investors, CEOs, and Functional | Department Heads.

Expertise is in strategy, corporate and business development, marketing and financial assessments, and innovation.

I provide sophisticated quantitative and qualitative analysis, backing strategically sound scenarios and recommendations. This is based on deep real-world experience, and an ability to quickly assess technologies and markets. I have a knack for cutting through complex problems with specific, fact-based solutions.

Website Built with WordPress.com.

Follow Following
- Biomarkers, Diagnostics, and More
- Already have a WordPress.com account? Log in now.